Home

Developing Therapies for Rhodopsin Retinitis Pigmentosa (360G-tnlcomfund-0030106089)

Funding Organisation
£247,201
Recipient Organisation

This study aims to continue the pre-clinical development of potential treatments for rhodopsin retinitis pigmentosa, which causes blindness due to the progressive degeneration of rod and cone photoreceptors in the retina. There are currently no effective treatments for RP. In particular, the study will test the in vivo efficacy of the most effective drugs from our initial in vitro screen and identify new effective compounds that may be more suitable for clinical application.

Where is this data from?

This data was originally published by The National Lottery Community Fund. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.

Grant Details

Amount Applied For 250832
Amount Awarded 247201
Award Date 2008-11-20T00:00:00+00:00
Grant Programme: Code RGT1
Grant Programme: Title Research Grants
Last Modified 2016-05-11T14:05:00Z
Planned Dates: Duration (months) 36
Planned Dates: Start Date 2009-05-31T00:00:00+00:00
Recipient Org: Charity Number 271729
Recipient Org: Location: Geographic Code E05002599
Recipient Org: Location: Geographic Code E07000004
Recipient Org: Location: Name Aylesbury Vale
Recipient Org: Location: Name Buckingham North
Recipient Org: Organisation Type Charity : Registered Charity

Allow analytics cookies?
More Information & Privacy Policy

Yes No Disable Analytics